Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma

Joseph Michael Yardman‐Frank ,Lidia Sacchetto,Peter A Kanetsky,Alison Venn,Stephen B Gruber,Stefano Rosso,Klaus J Busam,Irene Orlow,Anne Kricker,Anne E Cust,Bruce K Armstrong,Li Luo,Nancy E Thomas,Loraine D Marrett,Baillie Bronner,Lynn From,Roberto Zanetti,Marianne Berwick,Colin B Begg ,Pam Groben,Terry Dwyer,Hoda Anton‐Culver ,R P Gallagher ,Paul Tucker,Gem Study Team

doi:10.1016/j.jdin.2021.04.002

Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma

Joseph Michael Yardman‐Frank , Lidia Sacchetto + Show 23 more

Open Access

https://doi.org/10.1016/j.jdin.2021.04.002

Copy DOI

Journal: JAAD International	Publication Date: Jun 1, 2021
Citations: 3	License type: cc-by-nc-nd

Affiliation: University of New Mexico, Piedmont Reference Center for Epidemiology and Cancer Prevention, University of Pennsylvania, Philadelphia University, Menzies School of Health Research, University of Michigan–Ann Arbor, Memorial Sloan Kettering Cancer Center, University of Sydney, UNSW Sydney, University of North Carolina at Chapel Hill, Cancer Care Ontario, University of California, Irvine, BC Cancer Agency

#Shorter Recurrence-free Times #Histopathologic Subtype + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

To the Editor: As of 2019 National Cancer Institute data show that melanoma is the fifth most common cancer in the United States.1 There has been a recent push to include the histopathologic subtype of nodular melanoma as an independent prognostic classifier due to the identification of associated aggressive histopathologic characteristics and shorter recurrence-free times.2,3

Full Text